*(HealthDay News via Yahoo News) — Researchers studying the link between diabetes and a hormone that affects your so-called “body clock” have identified a genetic mutation in the receptor for the hormone, melatonin, that may to boost the risk of the disease.
The finding could help improve assessment of a person’s diabetes risk and could also lead to the development of personalized treatments, according to the study published in the Jan. 29 online edition of the journal Nature Genetics.
The research team from Imperial College London found that people who have rare genetic mutations in the receptor for melatonin have a greatly increased risk for type 2 diabetes.
Melatonin controls the body’s sleep-wake cycle. A previous study found that people with common variations in the gene for the melatonin receptor MT2 have a slightly increased risk for type 2 diabetes.
This new study discovered that having any of four rare mutations of the MT2 is associated with a six times increased risk of developing type 2 diabetes.
Read/learn more at Yahoo News.
Want to read more articles like this one? Subscribe to EURnewsletter.
Got A News Tip or Video You Want to Share? Contact us HERE.
- The Socialist's Journal: Blake Lively
- Dr. Kenneth C. Ulmer and David Sigel Announce TUI
- 'It Got Better': Raven Symone Talks Sexuality & Coming Out (WATCH)
- THE (05-24-16) EURweb Free-4-All Page
- Oscar Generale & Denny Mendez Shopping for Baby Clothes?
- Lynn Whitfield Dishes on Her Dramatic Face Off With Oprah! (WATCH)
- Yes, Wendy Williams Had Plenty to Say About the Tamar/'The Real' Situation (WATCH)
- Bombshell Report: Bill Cosby Admitted to Sex with Teens!
- Floyd Mayweather Hired Drake, Future For Daughter’s Sweet Sixteen
- Donald Trump Lists Oakland as 'Most Dangerous City in the World'
- Discover More Stories on EURweb: Click Here